Jade Biosciences, Inc. SEC filings JBIO
Jade Biosciences, Inc. has 509 filings in SEC EDGAR's recent list, going back to Jan 8, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 1, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 26, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 11, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Other events
|
Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 22, 2026 | Apr 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 5, 2026 | Jan 5, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 15, 2025 | Dec 13, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 14, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 7, 2025 | Oct 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 9, 2025 | Sep 5, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Jul 1, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Acquisition or sale of assets, Results of operations, Regulation FD disclosure
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
May 1, 2025 | Apr 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 29, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Other events
|
Apr 23, 2025 | Apr 23, 2025 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure, Other events
|
Apr 21, 2025 | Apr 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 9, 2025 | Apr 9, 2025 |
| 8-K |
Current report
Other events
|
Apr 9, 2025 | Apr 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 7, 2025 | Apr 7, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure
|
Oct 31, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 17, 2024 | Oct 11, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2024 | Oct 6, 2024 |
| 8-K |
Current report
Other events
|
Jul 8, 2024 | Jul 8, 2024 |
| 8-K/A |
Amended current report
Exit or restructuring costs
|
Jul 1, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Exit or restructuring costs
|
Jun 28, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 17, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 20, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2023 | Jul 10, 2023 |
| 8-K |
Current report
Other events
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 5, 2023 | Apr 5, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2023 | Mar 29, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 23, 2023 | Jan 19, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2022 | Jun 21, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Apr 29, 2022 | Apr 26, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 15, 2021 | Dec 15, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2021 | Aug 16, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 12, 2021 | Aug 6, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 19, 2021 | Jul 15, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 2, 2021 | Jun 29, 2021 |
Showing 60 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1798749
- Former names
- Aerovate Therapeutics, Inc. (until Apr 30, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.